Biochem Soc Trans 2014
CPT II deficiency The adult CPT II clinical phenotype is somewhat benign and requires additional external triggers such as high-intensity exercise before the predominantly myopathic symptoms are elicited
By drug type, the tirzepatide segment is expected to expand at the fastest CAGR between 2026 and 2035
Clostridium butyricum 10 is known for its butyrate-producing capabilities
Simone Palma Favaro, Embrapa Agroenergia, Brazil Updates Copyright 2022 Yuan, Wang, Jin, Mi, Pang, Liu, Gong, Sun, Li, Wei, Jin and Wang
Modification of cochrane tool to assess risk of bias in randomized trials